Silicon Valley Executives Join Trump at White House to Back “Super Intelligence” Push Amid Rising AI Backlash

Silicon Valley’s most prominent executives have long presented themselves as people who can see around corners. But in the final stretch before the midterm elections, a number of them traveled to the White House to appear alongside President Donald Trump and publicly support his “Super Intelligence” agenda—at a moment when backlash against artificial intelligence and the construction of energy-hungry data centers has been intensifying.

The move, coming roughly five weeks before voters head to the polls, is increasingly being viewed inside tech as a high-stakes political gamble that didn’t account for how volatile the environment around AI has become. By tying their brands and companies to Trump so publicly, the leaders involved may have misjudged not just where public opinion is headed, but how quickly AI policy—and the politics surrounding it—can shift. The episode is raising a more existential question for an industry built on confident predictions: if these leaders truly understand the future, why did they misread the present?

Meanwhile, on Capitol Hill, a separate debate about AI hardware is gaining momentum. Illinois Democratic representative Bill Foster says Nvidia has told him it is technically possible to add anti-smuggling safeguards envisioned by the proposed Chip Security Act. Foster, a member of the House Committee on Science, Space, and Technology and a cosponsor of the bill, described those discussions in comments to MIT Technology Review on Thursday.

The legislation would require advanced AI chips to include location-verification capabilities—geotracking measures designed to confirm where chips end up and to help stop diversion to China. The proposal has resurfaced amid heightened scrutiny of Nvidia and the AI chip supply chain, particularly as questions mount about how restricted hardware can move through third countries and intermediaries.

Foster’s account directly contradicts the position of at least one industry group, which has argued that the kinds of tracking requirements contemplated by the Chip Security Act may be “potentially infeasible.” But Foster says Nvidia’s representatives indicated otherwise, suggesting there may be more room for compromise on technical design than the public lobbying battle implies. The bill’s renewed visibility also comes as Nvidia faces turbulence at the top following CEO Jensen Huang’s resignation, an upheaval compounded by reports of an affair.

Beyond chips and politics, a quieter fight over rights and recognition is playing out in neuroscience. Researchers have spent decades trying to interpret brain signals well enough to translate neural activity into actions—work that has led to implants capable of controlling robotic limbs, operating computers, and even generating speech. That progress depends on volunteers willing to undergo invasive experimental procedures, and one of them is now pushing for stronger protections.

Ian Burkhart, who received a brain implant in 2014, is advocating guidelines for ethical clinical trials that better respect participants’ autonomy. Among his priorities: ensuring that people who contribute their brain data can access that information whenever they choose, and that their role is treated as a central part of the scientific enterprise rather than an afterthought.

The broader tech world also grappled with immediate disruption Thursday as a major Microsoft outage rippled across global services, affecting products including Outlook, Teams, and Copilot. Microsoft said the incident was not the result of a cybersecurity attack.

Why it matters

AI’s next phase will be shaped as much by political alignment and public trust as by technical capability. If Washington moves toward geotracking requirements for advanced chips, it could meaningfully alter how AI hardware is sold, secured, and audited worldwide—especially as the US tries to restrict access in China. At the same time, debates over brain-implant ethics signal a growing demand for clearer participant rights as neurotechnology begins moving from labs toward wider use.